eMedicine Specialties > Dermatology > Internal Medicine

Cutaneous Manifestations of Cholesterol Embolism: Multimedia

Author: Laura F McGevna, University of Vermont College of Medicine
Coauthor(s): Molly T Hogan, MD, Resident Physician, Department of Dermatology, University of Minnesota Medical School; Gregory J Raugi, MD, PhD, Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle
Contributor Information and Disclosures

Updated: Feb 23, 2009

Multimedia

A 76-year-old man with a history of aortobifemora...Media file 1: A 76-year-old man with a history of aortobifemoral bypass graft developed this eruption after an angiographic procedure. This image shows the plantar surface of the right foot with some of the discoloration resulting from petechiae arranged in a reticulated pattern. This is not livedo reticularis. Petechiae do not blanch on diascopy, but the lesions of livedo reticularis do blanch.
A 76-year-old man with a history of aortobifemora...

A 76-year-old man with a history of aortobifemoral bypass graft developed this eruption after an angiographic procedure. This image shows the plantar surface of the right foot with some of the discoloration resulting from petechiae arranged in a reticulated pattern. This is not livedo reticularis. Petechiae do not blanch on diascopy, but the lesions of livedo reticularis do blanch.

Aorta with an ulcerated plaque (black arrowhead) ...Media file 2: Aorta with an ulcerated plaque (black arrowhead) on the luminal side photographed under water to enhance reflection of cholesterol crystals (white arrowhead).
Aorta with an ulcerated plaque (black arrowhead) ...

Aorta with an ulcerated plaque (black arrowhead) on the luminal side photographed under water to enhance reflection of cholesterol crystals (white arrowhead).

Low-power view of a skin biopsy specimen demonstr...Media file 3: Low-power view of a skin biopsy specimen demonstrating an arteriole within the subcutaneous fat occluded with thrombus material that contains (black arrowhead) needle-shaped cholesterol clefts (hematoxylin and eosin stain, original magnification X40).
Low-power view of a skin biopsy specimen demonstr...

Low-power view of a skin biopsy specimen demonstrating an arteriole within the subcutaneous fat occluded with thrombus material that contains (black arrowhead) needle-shaped cholesterol clefts (hematoxylin and eosin stain, original magnification X40).

High-power view of occluded vessel (hematoxylin a...Media file 4: High-power view of occluded vessel (hematoxylin and eosin stain, original magnification X100). Same patient as in Media File 3.
High-power view of occluded vessel (hematoxylin a...

High-power view of occluded vessel (hematoxylin and eosin stain, original magnification X100). Same patient as in Media File 3.

Symmetric involvement of the feet with livedo ret...Media file 5: Symmetric involvement of the feet with livedo reticularis on the plantar surface of the forefoot and cyanosis of the left fifth toe. The painful cyanotic toe is typical of blue toe syndrome.
Symmetric involvement of the feet with livedo ret...

Symmetric involvement of the feet with livedo reticularis on the plantar surface of the forefoot and cyanosis of the left fifth toe. The painful cyanotic toe is typical of blue toe syndrome.

Dorsal surface of the toes of the right foot (sam...Media file 6: Dorsal surface of the toes of the right foot (same patient as in Media File 1). This image shows cyanosis of the fourth toe. The dominant eruption is petechial. Note the pallor of the tip of the great toe and the second toe. This finding indicates acute loss of perfusion.
Dorsal surface of the toes of the right foot (sam...

Dorsal surface of the toes of the right foot (same patient as in Media File 1). This image shows cyanosis of the fourth toe. The dominant eruption is petechial. Note the pallor of the tip of the great toe and the second toe. This finding indicates acute loss of perfusion.

Plantar surface of the right foot. The distal hal...Media file 7: Plantar surface of the right foot. The distal half of the great toe is gangrenous, with a sharp demarcation between the necrotic tissue and the normal proximal skin. Livedo reticularis is present on the distal plantar forefoot, and petechiae are present on the distal pad of the second and fourth toes.
Plantar surface of the right foot. The distal hal...

Plantar surface of the right foot. The distal half of the great toe is gangrenous, with a sharp demarcation between the necrotic tissue and the normal proximal skin. Livedo reticularis is present on the distal plantar forefoot, and petechiae are present on the distal pad of the second and fourth toes.

The lower extremities show well-developed livedo ...Media file 8: The lower extremities show well-developed livedo reticularis and focal areas of erosion and ulceration.
The lower extremities show well-developed livedo ...

The lower extremities show well-developed livedo reticularis and focal areas of erosion and ulceration.

Photomicrographs of histologic sections of an aor...Media file 9: Photomicrographs of histologic sections of an aorta with van Gieson stain. (Left) An atherosclerotic plaque with the fibrous cap (black arrowhead) overlying a necrotic core of cellular debris, extracellular lipids, and cholesterol clefts (white arrowhead). Underneath the plaque is the elastic media (arrow). (Right) A ruptured atherosclerotic plaque exposing the atheromatous debris containing cholesterol crystals to the bloodstream on the luminal side of the aorta.
Photomicrographs of histologic sections of an aor...

Photomicrographs of histologic sections of an aorta with van Gieson stain. (Left) An atherosclerotic plaque with the fibrous cap (black arrowhead) overlying a necrotic core of cellular debris, extracellular lipids, and cholesterol clefts (white arrowhead). Underneath the plaque is the elastic media (arrow). (Right) A ruptured atherosclerotic plaque exposing the atheromatous debris containing cholesterol crystals to the bloodstream on the luminal side of the aorta.

CT scan of an infrarenal abdominal aortic aneurys...Media file 10: CT scan of an infrarenal abdominal aortic aneurysm showing the mural thrombosis (white arrowhead) and the bright atherosclerotic calcifications (black arrowhead).
CT scan of an infrarenal abdominal aortic aneurys...

CT scan of an infrarenal abdominal aortic aneurysm showing the mural thrombosis (white arrowhead) and the bright atherosclerotic calcifications (black arrowhead).

More on Cutaneous Manifestations of Cholesterol Embolism

Overview: Cutaneous Manifestations of Cholesterol Embolism
Differential Diagnoses & Workup: Cutaneous Manifestations of Cholesterol Embolism
Treatment & Medication: Cutaneous Manifestations of Cholesterol Embolism
Follow-up: Cutaneous Manifestations of Cholesterol Embolism
Multimedia: Cutaneous Manifestations of Cholesterol Embolism
References

References

  1. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. Oct 1987;38(10):769-84. [Medline].

  2. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis. May 1999;33(5):840-50. [Medline].

  3. Brown NJ, Morgan HJ. Spontaneous cholesterol emboli presenting as livedo reticularis. J Tenn Med Assoc. Feb 1992;85(2):64. [Medline].

  4. Enomae M, Takeda S, Yoshimoto K, Takagawa K. Chronic cholesterol crystal embolism with a spontaneous onset. Intern Med. 2007;46(14):1123-6. [Medline].

  5. Gore I, Collins DP. Spontaneous atheromatous embolization. Review of the literature and a report of 16 additional cases. Am J Clin Pathol. May 1960;33:416-26. [Medline].

  6. Klein R, Klein BE, Moss SE, Meuer SM. Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Arch Ophthalmol. Oct 2003;121(10):1446-51. [Medline].

  7. Moolenaar W, Lamers CB. Cholesterol crystal embolization in the Netherlands. Arch Intern Med. Mar 25 1996;156(6):653-7. [Medline].

  8. Jucgla A, Moreso F, Muniesa C, Moreno A, Vidaller A. Cholesterol embolism: still an unrecognized entity with a high mortality rate. J Am Acad Dermatol. Nov 2006;55(5):786-93. [Medline].

  9. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. Jun 2003;14(6):1584-90. [Medline].

  10. Manganoni AM, Venturini M, Scolari F, et al. The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. Br J Dermatol. Jun 2004;150(6):1230-1. [Medline].

  11. Karmody AM, Powers SR, Monaco VJ, Leather RP. "Blue toe" syndrome. An indication for limb salvage surgery. Arch Surg. Nov 1976;111(11):1263-8. [Medline].

  12. Scolari F, Ravani P, Gaggi R, et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation. Jul 17 2007;116(3):298-304. [Medline].

  13. Tappenden J, Suvarna SK, Ackroyd R. Cholesterol crystal embolization leading to perforation of the gallbladder. Hepatobiliary Pancreat Dis Int. 2007;6:653-655.

  14. Sarwar S, Al-Absi A, Wall BM. Catastrophic cholesterol crystal embolization after endovascular stent placement for peripheral vascular disease. Am J Med Sci. May 2008;335(5):403-6. [Medline].

  15. Takahashi K, Iijima K, Nagasaki M, Torii I, Yamaguchi S, Kobayashi S. Deterioration of vascular dementia caused by recurrent multiple small emboli from thoracic aortic atheroma. Intern Med. Jul 2004;43(7):607-11. [Medline].

  16. Vacher-Coponat H, Pache X, Dussol B, Berland Y. Pulmonary-renal syndrome responding to corticosteroids: consider cholesterol embolization. Nephrol Dial Transplant. Sep 1997;12(9):1977-9. [Medline].

  17. Reuter MD, Chor PJ, Dehlendorf A, Alpert MA. Spontaneous cholesterol crystal embolization to bone marrow. South Med J. May 2007;100(5):533-6. [Medline].

  18. Pierce JR Jr, Wren MV, Cousar JB Jr. Cholesterol embolism: diagnosis antemortem by bone marrow biopsy. Ann Intern Med. Dec 1978;89(6):937-8. [Medline].

  19. Muretto P, Carnevali A, Ansini AL. Cholesterol embolism of bone marrow clinically masquerading as systemic or metastatic tumor. Haematologica. May-Jun 1991;76(3):248-50. [Medline].

  20. Glassock RJ, Ritz E, Bommer J, Andrassy K, Waldherr R. Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol. 1984;4(3):193-200. [Medline].

  21. Ridker PM, Michel T. Streptokinase therapy and cholesterol embolization. Am J Med. Sep 1989;87(3):357-8. [Medline].

  22. Schwartz MW, McDonald GB. Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA. Oct 9 1987;258(14):1934-5. [Medline].

  23. Dubel GJ, Murphy TP. Distal embolic protection for renal arterial interventions. Cardiovasc Intervent Radiol. Jan-Feb 2008;31(1):14-22. [Medline].

  24. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. Jul 16 2003;42(2):211-6. [Medline].

  25. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. Oct 1986;122(10):1194-8. [Medline].

  26. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol. May 2007;27(5):1159-65. [Medline].

  27. Sklar JL, Taira JW. Cholesterol emboli syndrome. Int J Dermatol. Aug 1993;32(8):607-9. [Medline].

  28. Wakabayashi T, Yoshizawa Y, Kawana S. Successful use of heparin and warfarin in the treatment of cholesterol crystal embolization. J Dermatol. Feb 2008;35(2):111-4. [Medline].

  29. Funabiki K, Masuoka H, Shimizu H, et al. Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. Jpn Heart J. Sep 2003;44(5):767-74. [Medline].

  30. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery. Jun 1989;105(6):737-46. [Medline].

  31. Finch TM, Ryatt KS. Livedo reticularis caused by cholesterol embolization may improve with simvastatin. Br J Dermatol. Dec 2000;143(6):1319-20. [Medline].

  32. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet. May 2 1998;351(9112):1331-2. [Medline].

  33. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ. Feb 2 2002;324(7332):268-9. [Medline].

  34. Carr ME Jr, Sanders K, Todd WM. Pain relief and clinical improvement temporally related to the use of pentoxifylline in a patient with documented cholesterol emboli--a case report. Angiology. Jan 1994;45(1):65-9. [Medline].

  35. Maeshima E, Yamada Y, Mune M, Yukawa S. A case of cholesterol embolism with ANCA treated with corticosteroid and cyclophosphamide. Ann Rheum Dis. Jul 2001;60(7):726. [Medline].

  36. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet. May 2 1998;351(9112):1331-2. [Medline].

  37. Filip JR, Dillon RS. Treatment of end-stage "trash feet" with the end-diastolic pneumatic boot. Angiology. Apr-May 2008;59(2):214-9. [Medline].

  38. Carroccio A, Olin JW, Ellozy SH, et al. The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. J Vasc Surg. Sep 2004;40(3):424-9. [Medline].

  39. Eggebrecht H, Oldenburg O, Dirsch O, et al. Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization:: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv. Apr 2000;49(4):389-94. [Medline].

  40. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. Nov 2003;38(5):962-8. [Medline].

  41. Whitlow PL, Lylyk P, Londero H, et al. Carotid artery stenting protected with an emboli containment system. Stroke. May 2002;33(5):1308-14. [Medline].

  42. Siablis D, Karnabatidis D, Katsanos K, Ravazoula P, Kraniotis P, Kagadis GC. Outflow protection filters during percutaneous recanalization of lower extremities' arterial occlusions: a pilot study. Eur J Radiol. Aug 2005;55(2):243-9. [Medline].

  43. Cardaioli P, Rigatelli G, Arboit M, Giordan M, Roncon L. Treatment of cholesterol crystal embolisation syndrome with filter-assisted stenting. J Cardiovasc Med (Hagerstown). Nov 2007;8(11):953-5. [Medline].

  44. Lund C, Hol PK, Lundblad R, et al. Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg. Sep 2003;76(3):765-70; discussion 770. [Medline].

  45. Abdelmalek MF, Spittell PC. 79-year-old woman with blue toes. Mayo Clin Proc. Mar 1995;70(3):292-5. [Medline].

  46. Anderson WR. Necrotizing angitis associated with embolization of cholesterol. Case report, with emphasis on the use of the muscle biopsy as a diagnostic aid. Am J Clin Pathol. Jan 1965;43:65-71. [Medline].

  47. Applebaum RM, Kronzon I. Evaluation and management of cholesterol embolization and the blue toe syndrome. Curr Opin Cardiol. Sep 1996;11(5):533-42. [Medline].

  48. Bauwens F, Duprez D, Clement DL. Relapsing digital ulcers. Acta Cardiol. 1989;44(4):323-7. [Medline].

  49. Becker KA, Schwartz RA, Rothenberg J. Leg ulceration and the cholesterol embolus. J Med. 1997;28(5-6):387-92. [Medline].

  50. Belenfant X, Bariety J, Meyrier A, Jacquot C. An intensive care, adapted Rx schedule reduces mortality in multivisceral cholesterol emboli with acute renal failure (abstract). J Am Soc Nephrol. 1997;8:122A.

  51. Ben-Horin S, Bardan E, Barshack I, Zaks N, Livneh A. Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism. Am J Gastroenterol. Jul 2003;98(7):1471-9. [Medline].

  52. Bhalla A, Gupta S, Jain AP, Jajoo UN, Gupta OP, Kalantri SP. Blue toe syndrome: a rare complication of acute pancreatitis. JOP. Jan 2003;4(1):17-9. [Medline].

  53. Blackshear JL, Oldenburg WA, Cohen MD. Making the diagnosis when the patient has 'blue toes'. Geriatrics. Dec 1994;49(12):37-9, 43-5. [Medline].

  54. Blankenship JC, Butler M, Garbes A. Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest. Mar 1995;107(3):662-8. [Medline].

  55. Borrego L, Gil R, Mazuecos A, Ruiz R, Lopez JL, Iglesias L. Cholesterol embolism to the skin. Clin Exp Dermatol. Nov 1992;17(6):424-6. [Medline].

  56. Brenowitz JB, Edwards WS. The management of atheromatous emboli to the lower extremities. Surg Gynecol Obstet. Dec 1976;143(6):941-5. [Medline].

  57. Cabili S, Hochman I, Goor Y. Reversal of gangrenous lesions in the blue toe syndrome with lovastatin--a case report. Angiology. Oct 1993;44(10):821-5. [Medline].

  58. Chandrashekariah R, Fresko O, Lynfield YL. Cholesterol embolism: a case report and review of the literature. Cutis. Oct 2001;68(4):263-7. [Medline].

  59. Chaudhary K, Wall BM, Rasberry RD. Livedo reticularis: an underutilized diagnostic clue in cholesterol embolization syndrome. Am J Med Sci. May 2001;321(5):348-51. [Medline].

  60. Chesney TM. Atheromatous embolization to the skin. Am J Dermatopathol. Jun 1982;4(3):271-3. [Medline].

  61. Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP. Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine (Baltimore). Nov 1988;67(6):389-400. [Medline].

  62. Cross SS. How common is cholesterol embolism?. J Clin Pathol. Oct 1991;44(10):859-61. [Medline].

  63. Darsee JR. Cholesterol embolism: the great masquerader. South Med J. Feb 1979;72(2):174-80. [Medline].

  64. Davies DJ, Thurasingham K. Intractable leg ulceration caused by cutaneous cholesterol embolism. Med J Aust. Aug 17 1992;157(4):267-8. [Medline].

  65. Day LL, Aterman K. Hemorrhagic panniculitis caused by atheromatous embolization. A case report and brief review. Am J Dermatopathol. Oct 1984;6(5):471-8. [Medline].

  66. Delen S, Boonen A, Landewe R, Kroon AA, van der Linden S, Tervaert JW. An unusual case of ANCA positive disease. Ann Rheum Dis. Aug 2003;62(8):780-1. [Medline].

  67. Deschamps P, Leroy D, Mandard JC. Cutaneous crystal cholesterol emboli. Acta Derm Venereol. 1980;60(3):266-9. [Medline].

  68. Deschamps P, Leroy D, Mandard JC, Heron JF, Lauret P. Livedo reticularis and nodules due to cholesterol embolism in the lower extremities. Br J Dermatol. Jul 1977;97(1):93-7. [Medline].

  69. Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol. Sep 2003;17(5):504-11. [Medline].

  70. Drost H, Buis B, Haan D, Hillers JA. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J. Sep 1984;52(3):339-42. [Medline].

  71. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. Jul 2006;44(1):128-35. [Medline].

  72. Eliot RS, Kanjuh VI, Edwards JE. Atheromatous embolism. Circulation. Oct 1964;30:611-8. [Medline].

  73. Erdim M, Tezel E, Biskin N. A case of skin necrosis as a result of cholesterol crystal embolisation. J Plast Reconstr Aesthet Surg. 2006;59(4):429-32. [Medline].

  74. Flory CM. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol. 1945;21:549-64.

  75. Graziani G, Santostasi S, Angelini C, Badalamenti S. Corticosteroids in cholesterol emboli syndrome. Nephron. Apr 2001;87(4):371-3. [Medline].

  76. Hasegawa M, Sugiyama S. Apheresis in the treatment of cholesterol embolic disease. Ther Apher Dial. Aug 2003;7(4):435-8. [Medline].

  77. Hendrickx I, Monti M, Manasse E, Gallotti R. Severe cutaneous cholesterol emboli syndrome after coronary angiography. Eur J Cardiothorac Surg. Feb 1999;15(2):215-7. [Medline].

  78. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg. Jun 2005;41(6):1026-30. [Medline].

  79. Hitti WA, Anderson J. Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy. South Med J. Feb 2005;98(2):235-7. [Medline].

  80. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med. Jun 1987;82(6):1233-7. [Medline].

  81. Joakimsen O, Bonaa KH, Stensland-Bugge E, Jacobsen BK. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: the Tromsø Study. Arterioscler Thromb Vasc Biol. Dec 1999;19(12):3007-13. [Medline].

  82. Jönsson H, Holm C, Nilsson A, Petersson F, Johnsson P, Laurell T. Particle separation using ultrasound can radically reduce embolic load to brain after cardiac surgery. Ann Thorac Surg. Nov 2004;78(5):1572-7. [Medline].

  83. Kalter DC, Rudolph A, McGavran M. Livedo reticularis due to multiple cholesterol emboli. J Am Acad Dermatol. Aug 1985;13(2 Pt 1):235-42. [Medline].

  84. Kang K, Botella R, White CR Jr. Subtle clues to the diagnosis of cholesterol embolism. Am J Dermatopathol. Aug 1996;18(4):380-4. [Medline].

  85. Kaplan-Pavlovcic S, Vizjak A, Vene N, Ferluga D. Antineutrophil cytoplasmic autoantibodies in atheroembolic disease. Nephrol Dial Transplant. Apr 1998;13(4):985-7. [Medline].

  86. Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med. Aug 1987;147(8):1384-5. [Medline].

  87. Kawakami Y, Hirose K, Watanabe Y, et al. Management of multiple cholesterol embolization syndrome--a case report. Angiology. Mar 1990;41(3):248-52. [Medline].

  88. Kusaba A, Imayama S, Furue M. Delayed appearance of livedo reticularis in 3 cases with a cholesterol embolism. Arch Dermatol. Jun 1999;135(6):725-6. [Medline].

  89. Lim J, Ramachandran R, Madhok R, Capell H. An unusual case of "giant cell arteritis". Ann Rheum Dis. Oct 2004;63(10):1347-8. [Medline].

  90. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens. Aug 2001;14(8 Pt 1):831-4. [Medline].

  91. Matsumura T, Matsumoto A, Ohno M, et al. A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids. Am J Med Sci. May 2006;331(5):280-3. [Medline].

  92. Maurizi CP, Barker AE, Trueheart RE. Atheromatous emboli. A postmortem study with special reference to the lower extremities. Arch Pathol. Nov 1968;86(5):528-34. [Medline].

  93. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med. May 1996;100(5):524-9. [Medline].

  94. Meenakshi-Sundaram S, Palanirajan S, Mani R, Sridhar R, Jithendrian JJ, Sundar B. Cognitive dysfunction in cholesterol embolic disease. J Neurol Sci. Oct 15 2004;225(1-2):161-4. [Medline].

  95. Moldveen-Geronimus M, Merriam JC Jr. Cholesterol embolization. From pathological curiosity to clinical entity. Circulation. May 1967;35(5):946-53. [Medline].

  96. Morales JM, Gonzalez E. Cholesterol crystal embolization. Blood Purif. 2006;24(5-6):431-2. [Medline].

  97. Om A, Ellahham S, DiSciascio G. Cholesterol embolism: an underdiagnosed clinical entity. Am Heart J. Nov 1992;124(5):1321-6. [Medline].

  98. Otsubo H, Kaito K, Takahashi H, et al. Cholesterol emboli following percutaneous transluminal coronary angioplasty as speculated by toe skin biopsy. Intern Med. Feb 1995;34(2):134-7. [Medline].

  99. Peat DS, Mathieson PW. Cholesterol emboli may mimic systemic vasculitis. BMJ. Aug 31 1996;313(7056):546-7. [Medline].

  100. Pennington M, Yeager J, Skelton H, Smith KJ. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors. Br J Dermatol. Mar 2002;146(3):511-7. [Medline].

  101. Quintart C, Treille S, Lefebvre P, Pontus T. Penile necrosis following cholesterol embolism. Br J Urol. Aug 1997;80(2):347-8. [Medline].

  102. Radauceanu A, Avignon A, Ribstein J, Monnier L. Use of a prostacyclin analogue in cholesterol crystal embolism. Diabet Med. Mar 1998;15(3):262-3. [Medline].

  103. Ramirez G, O'Neill WM Jr, Lambert R, Bloomer HA. Cholesterol embolization: a complication of angiography. Arch Intern Med. Sep 1978;138(9):1430-2. [Medline].

  104. Richards AM, Eliot RS, Kanjuh VI, Bloemendaal RD, Edwards JE. Cholesterol embolism: a multiple-system disease masquerading as polyarteritis nodosa. Am J Cardiol. May 1965;15:696-707. [Medline].

  105. Robinson RJ, Pemberton M, Goddard MJ. Myositis due to cholesterol emboli. Postgrad Med J. Dec 1993;69(818):947-9. [Medline].

  106. Rodot S, Lacour JP, Van Elslande L, Perrin C, Castanet J, Ortonne JP. Cholesterol crystal embolization presenting as erythema induratum of bazin. Acta Derm Venereol. Mar 1995;75(2):160-1. [Medline].

  107. Rosansky SJ. Multiple cholesterol emboli syndrome. South Med J. Jun 1982;75(6):677-80. [Medline].

  108. Rosman HS, Davis TP, Reddy D, Goldstein S. Cholesterol embolization: clinical findings and implications. J Am Coll Cardiol. May 1990;15(6):1296-9. [Medline].

  109. Scholten E, Crolla RM, Blomjous FJ, Moll FL. Preputial necrosis as an unusual cutaneous manifestation of cholesterol crystal embolization. J Urol. Mar 1995;153(3 Pt 1):741-2. [Medline].

  110. Scolari F, Bracchi M, Valzorio B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. Aug 1996;11(8):1607-12. [Medline].

  111. Sheehan MG, Condemi JJ, Rosenfeld SI. Position dependent livedo reticularis in cholesterol emboli syndrome. J Rheumatol. Nov 1993;20(11):1973-4. [Medline].

  112. Sijpkens Y, Westendorp R, van Kemenade F, van Duinen S, Breedveld F. Vasculitis due to cholesterol embolism. Am J Med. Mar 1997;102(3):302-3. [Medline].

  113. Sklar JL, Taira JW. Cholesterol emboli syndrome. Int J Dermatol. Aug 1993;32(8):607-9. [Medline].

  114. Tamura K, Umemura M, Yano H, et al. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol. Mar 2003;7(1):67-71. [Medline].

  115. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med. Sep 5 1957;257(10):442-7. [Medline].

  116. Theriault J, Agharazzi M, Dumont M, Pichette V, Ouimet D, Leblanc M. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract. 2003;94(1):c11-8. [Medline].

  117. Tran T, Morgan J, Morgan MB. Perplexing papules and plaques. Am J Dermatopathol. Aug 2002;24(4):374-6. [Medline].

  118. Tsunoda S, Daimon S, Miyazaki R, Fujii H, Inazu A, Mabuchi H. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. Nephrol Dial Transplant. Apr 1999;14(4):1041-2. [Medline].

  119. van de Ven PJ, Beutler JJ. The spotty sign. Nephrol Dial Transplant. Feb 1998;13(2):515-6. [Medline].

  120. van Heesewijk HP, Vos JA, Louwerse ES, et al. New brain lesions at MR imaging after carotid angioplasty and stent placement. Radiology. Aug 2002;224(2):361-5. [Medline].

  121. Vanhooteghem O, Papadopoulos T, Sass U, Gheeraert P, Cogan E, Song M. Clinical manifestations of cholesterol crystal embolism with subungual haemorrhages: a possible relationship?. Dermatology. 1996;192(4):395-7. [Medline].

  122. Verneuil L, Ze Bekolo R, Dompmartin A, Comoz F, Marcelli C, Leroy D. Efficiency of colchicine and corticosteroids in a leg ulceration with cholesterol embolism in a woman with rheumatoid arthritis. Rheumatology (Oxford). Aug 2003;42(8):1014-6. [Medline].

  123. Williams HC, Pembroke AC. Livedo reticularis and massive thoracoabdominal aneurysm. Clin Exp Dermatol. Jul 1994;19(4):353-5. [Medline].

  124. Zaytsev P, Miller K, Pellettiere EV. Cutaneous cholesterol emboli with infarction clinically mimicking heparin necrosis--a case report. Angiology. Jun 1986;37(6):471-6. [Medline].

Further Reading

Keywords

cholesterol embolism CE, cholesterol embolism syndrome, CE syndrome, atheroembolization, cholesterol crystal embolization, multiple cholesterol emboli syndrome, cholesterol microembolization, cholesterol emboli, atheromatous embolization, atherosclerosis, atherosclerotic cardiovascular disease, microthrombi, limb ischemia

Contributor Information and Disclosures

Author

Laura F McGevna, University of Vermont College of Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Molly T Hogan, MD, Resident Physician, Department of Dermatology, University of Minnesota Medical School
Molly T Hogan, MD is a member of the following medical societies: Alpha Omega Alpha
Disclosure: Nothing to disclose.

Gregory J Raugi, MD, PhD, Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle
Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Catharine Lisa Kauffman, MD, FACP, Georgetown Dermatology and Georgetown Dermpath
Catharine Lisa Kauffman, MD, FACP is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Royal Society of Medicine, Society for Investigative Dermatology, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Warren R Heymann, MD, Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey
Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.